Stage one of the federal hemp redefinition takes effect November 12: products built on cannabinoids the cannabis plant cannot naturally produce lose their hemp status. The bigger cliff — the 0.4-milligram cap — still waits until December 11.
The first federal restriction takes effect today
One year after Congress rewrote the federal definition of hemp, the first stage of that rewrite takes effect today, Thursday, November 12, 2026.
What changes is narrow but real: intermediate and final hemp-derived products containing cannabinoids that cannot be naturally produced by the Cannabis sativa L. plant are excluded from the hemp definition under the subclause-(I) exclusions of the redefinition Congress enacted in §781 of P.L. 119-37.
The clearest example is THC-O, which the Congressional Research Service identifies as a cannabinoid that does not occur naturally in cannabis. As of today, products built on cannabinoids in this class are no longer "hemp" under federal law.
The two-stage split exists because P.L. 119-103, the stopgap law President Trump signed September 2, 2026, delayed most of the redefinition in its §2019, but left this one piece on the original November 12 date.
The bigger THC restriction is still 29 days away
Everything the industry fears most is still a month away.
On December 11, 2026, the remaining provisions of the redefinition take effect. They include the new 0.3% total-THC definition, calculated on a dry-weight basis and including THCA; the separate exclusion for cannabinoids that can naturally occur in cannabis but were synthesized or manufactured outside the plant; and new restrictions on intermediate and finished products.
Intermediate products exceeding 0.3% combined total THC and other cannabinoids with THC-like effects will be excluded from hemp. Finished products containing more than 0.4 milligrams per retail container of combined total THC and other cannabinoids with similar or marketed-similar effects to THC will also be excluded.
The statute defines the container as the innermost packaging in direct contact with the finished product for retail sale. It does not establish a separate single-serving threshold.
Another unresolved issue is the FDA's missing guidance. The three cannabinoid lists and additional container guidance Congress ordered FDA to publish by February 10, 2026 — the material that would tell the industry exactly which cannabinoids and products fall where — still had not been published as of the latest Congressional Research Service review, as nuggnotes reported November 9.
The industry is being asked to comply with definitions the government itself has not finished writing.
Both sides are fighting over the next 29 days
Today starts a 29-day window, and both sides know it.
Hemp interests are pushing Congress for another reprieve. The Hemp Planting Predictability Act (H.R. 7024 / S. 3686) would stretch the implementation period to three years, pushing the deadline to November 2028. Rep. Nancy Mace's American Hemp Protection Act (H.R. 6209) would repeal §781 outright.
The other side is organizing to hold the December 11 date. A press conference organized by No Dangerous Intoxicating Products featured former White House official Cedric Richmond and former DEA Administrator Asa Hutchinson, who argued that the December 11 deadline should remain in place.
The fight also carries a White House subplot. This week, former HHS adviser Calley Means publicly accused departed chief of staff Susie Wiles of tilting hemp policy toward delay because her son-in-law runs a hemp company. The White House denies the accusation, as nuggnotes reported November 11.
What happens before December 11?
No public FDA or DEA enforcement statement specifically addressing today's effective-date change was identified in the records reviewed for this article.
What the statute does is definitional: products covered by today's exclusion no longer qualify as hemp under federal law. Under the Controlled Substances Act, they are controlled to the extent they fall within the federal definitions of marijuana or THC.
The next developments to watch before December 11 are the first FDA or DEA guidance, the first enforcement action, and whether Congress moves either reprieve bill.
nuggnotes will follow with an update when any of the three lands.
Sources
- §781 of P.L. 119-37 (federal hemp redefinition); §2019 of P.L. 119-103 (two-stage effective dates)
- Congressional Research Service, LSB11496
- Hemp Planting Predictability Act (H.R. 7024 / S. 3686); American Hemp Protection Act (H.R. 6209)
- Marijuana Moment newsletter, Nov. 11, 2026 (Richmond/Hutchinson effort)
Read next
Former RFK Jr. Aide Accuses Susie Wiles of Tilting Hemp Policy for Her Family. The White House Denies It.articles · Nov 11, 2026
FDA Gets New Cannabinoid Homework in Senate Bills as VA Marijuana Study Loses Its Deadlinearticles · Nov 11, 2026
Illinois Agrees to Delay Hemp Act Enforcement for About 250 Businessesarticles · Nov 10, 2026
0 comments